Interpreting isotretinoin dosing trials: Age, duration and statistical power
Journal of the European Academy of Dermatology and Venereology · 07.11.2026
DOI: 10.1111/jdv.70844 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of the European Academy of Dermatology and Venereology, online erschienen am 07.11.2026. Verfasst von Constantinos D Verros und 1 weiteren Autor:innen. Beteiligte Einrichtung: Private Dermatology Practice, Tripoli, Greece. Die Arbeit nennt 6 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Private Dermatology Practice, Tripoli, Greece.
- Department of Biomedical Sciences, University of West Attica, Athens, Greece.
ORCID-Profile: Constantinos D Verros, Efstathios A Rallis
Zitieren
APA
Verros, C. D., & Rallis, E. A. (2026). Interpreting isotretinoin dosing trials: Age, duration and statistical power. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70844
Vancouver
Verros CD, Rallis EA. Interpreting isotretinoin dosing trials: Age, duration and statistical power. Journal of the European Academy of Dermatology and Venereology. 2026. doi:10.1111/jdv.70844
BibTeX
@article{Verros2026,
author = {Verros, Constantinos D and Rallis, Efstathios A},
title = {Interpreting isotretinoin dosing trials: Age, duration and statistical power},
journal = {Journal of the European Academy of Dermatology and Venereology},
year = {2026},
doi = {10.1111/jdv.70844}
}
EUVIMED